Indeed, the most accepted AD theoretical model suggests that Aβ dysmetabolism triggers a cascade of downstream pathological events, including tau pathology, synaptic dysfunction, and neurodegeneration, which leads to cognitive decline and, ultimately, to dementia [4, 5]. The gene discussed is MAPT; the disease is Alzheimer disease.